Cytokinetics’ ALS programs may have seen better days, but its cardiovascular division has attracted well-backed partners, including Amgen and Royalty Pharma, who, in 2017 paid $90 million in exchange for a 4.5% royalty on their lead heart drug.
Now a C… […]
LOS ANGELES & SINGAPORE–(BUSINESS WIRE)–MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional association to… […]
A Peninsula biotech company is supplying a set of parasite-fighting preclinical compounds to a startup created by one of the scientists who co-founded the company more than two decades ago.
Kainomyx Inc. — launched by a Stanford University-connected t… […]
As Foster City-based Gilead Sciences moves forward with remdesivir and other Bay Area companies pursue new or repurposed drugs and vaccines against Covid-19 and the coronavirus that causes the disease, NIAID chief Dr. Tony Fauci talked in a webinar wit… […]
SAN FRANCISCO, July 13, 2020 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases,… […]
SAN JOSE, Calif., July 13, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and … […]
— INFINITY trial is currently enrolling patients with DME, the most common cause of vision loss in people with diabetic retinopathy — REDWOOD CITY, Calif., July 13, 2020 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-s… […]
SOUTH SAN FRANCISCO, July 13, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-thre… […]
Three biotech companies collectively raised $584 million in their initial public offerings last week, continuing a streak of IPOs that has the healthcare sector playing a leading role in the robust level of market activity this summer. Of the three com… […]
For the second time in less than two years, a U.K. drug industry trade group has reprimanded Gilead for disseminating information that unfairly compared one of its HIV drugs with… […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes
